FIELD: medicine.
SUBSTANCE: anti-tumour remedy includes, as active ingredients, tegafur in therapeutically efficient amount, gimeracil in amount efficient for enhancing anti-tumour effect, potassium oteracil in amount efficient for inhibiting side-effect, and at least one element selected from the group consisting of pholinic acid and its pharmacologically acceptable salts in amount efficient for enhancing anti-tumour effect. Molar ratio of tegafur: gimeracil: potassium oteracil: at least one element selected from group consisting of folinic acid and its pharmacologically acceptable salts is 1:0.4:1: 0.01 to 10. Application of combined medication tegafur/gimeracil/potassium oteracil in combination with potassium folinate essentially increases anti-tumour activity without aggravating toxicity.
EFFECT: enhanced anti-tumour effect.
13 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMOUR AGENT, KIT AND METHOD OF TREATING CANCER | 2009 |
|
RU2519199C2 |
| AGENT IMPROVING ANTI-CANCER EFFECT AND CONTAINING LIPOSOMAL AGENT CONTAINING OXALIPLATIN, AND ANTI-CANCER AGENT CONTAINING LIPOSOMAL AGENT | 2009 |
|
RU2492863C2 |
| AGENT INTENSIFYING ACTION OF ANTI-CANCER AGENTS | 2012 |
|
RU2589713C2 |
| THYMIDILATE SYNTHASE TARGETING RNAI MOLECULE AND USING IT | 2010 |
|
RU2535993C2 |
| ANTITUMOUR AGENT INTENSIFIER | 2010 |
|
RU2548913C2 |
| ANTITUMOR AGENT CONTAINING IMMUNOMODULATOR AND ANTITUMOR EFFECT ENHANCER | 2017 |
|
RU2747480C2 |
| DRUG AND COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS | 2017 |
|
RU2777595C2 |
| ANTITUMOR EFFECT AMPLIFYER CONTAINING IMIDAZOOXAAZINE COMPOUND | 2013 |
|
RU2618423C2 |
| METHOD FOR TREATING CANCER | 2002 |
|
RU2284184C2 |
| PEPTIDES WITH ANTI-TUMOUR ACTIVITY | 2024 |
|
RU2840111C1 |
